MetaCap

Abbott Laboratories (ABT) vs Novartis (NVS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Novartis (NVS) has outperformed Abbott Laboratories (ABT) over the past year, gaining 18.2% versus a loss of 19.6%. Over five years, NVS leads with a +86.5% price change compared with -18.2% for ABT. Novartis is the larger company by market cap ($284.18 billion vs $178.39 billion), about 1.6 times the size.

On valuation, Novartis trades at a lower forward P/E (15.1x vs 17.3x for Abbott Laboratories). Novartis offers the higher dividend yield (3.10% vs 2.45%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABT-19.60%NVS+18.19%
+36%-2%-39%
Nov 21, 20251 yearNov 20, 2026
ABT-18.80%NVS+84.26%
+113%+36%-41%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABT versus NVS key metrics
MetricABTNVS
Share price$103.00$150.47
Market cap$178.39B$284.18B
1-day change-0.84%-0.50%
YTD return-17.79%+9.14%
1-year return-19.60%+18.19%
5-year return-18.18%+86.46%
P/E ratio (TTM)38.4328.72
Forward P/E17.3515.15
EPS (TTM)$2.68$5.24
Dividend yield2.45%3.10%
Annual dividend$2.52$4.67
Revenue (latest FY)$44.33B—
Revenue growth (YoY)+5.67%—
Net income (latest FY)$6.52B$13.98B
Gross margin56.42%—
Operating margin18.17%—
Net margin14.72%—
52-week high$129.85$170.46
52-week low$81.97$126.50
Distance from 52-week high-20.68%-11.73%
Analyst consensusbuyhold
Avg. price target upside+15.45%+4.41%
Average volume8.89M2.18M
Shares outstanding1.73B1.89B
Employees122,00075,267
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NVS has outperformed ABT by 37.8 percentage points over the past year.
  • Abbott Laboratories trades at a higher earnings multiple (38.4x vs 28.7x trailing P/E).

About Abbott Laboratories

ABT stock →

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Health Care · Biotechnology: Pharmaceutical Preparations · 122,000 employees

About Novartis

NVS stock →

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure; Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6; Promacta/Revolade for immune thrombocytopenia (ITP), thrombocytopenia, and aplastic anemia patients; Tafinlar+Mekinist, an oral combination therapy to treat cancer patients; and Jakavi for treating myelofibrosis, polycythemia vera, and acute or chronic graftversushost disease.

Health Care · Biotechnology: Pharmaceutical Preparations · 75,267 employees

ABT vs NVS FAQ

Which is bigger, Abbott Laboratories or Novartis?

Novartis (NVS) is larger, with a market capitalization of $284.18B compared with $178.39B for Abbott Laboratories (ABT).

Which stock has performed better over the past year, ABT or NVS?

NVS returned +18.19% over the past 12 months, compared with -19.60% for ABT (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ABT or NVS?

NVS has the lower trailing P/E at 28.7, versus 38.4 for ABT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Abbott Laboratories or Novartis?

Novartis has the higher yield at 3.10%, compared with 2.45% for Abbott Laboratories.

Are Abbott Laboratories and Novartis in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons